SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ: ILMN) today announced the launch of the BeadXpress™ System. Based on its proprietary VeraCode™ digital microbead technology, this system represents a significant step forward for research and clinical development applications. Utilizing uniquely inscribed digital microbeads, VeraCode technology provides high-quality data, broad multiplexing capability, and assay flexibility. The two-color laser detection capability of the BeadXpress system is ideally suited for low- to mid multiplex experiments. Using this system, researchers can assay tens to hundreds of analytes in a single sample at one time. Key application areas include biomarker research and validation, pharmaceutical development, industrial testing, agriculture, clinical research, and the development of molecular diagnostic assays. BeadXpress systems and associated reagent kits are currently shipping.
